OptiDreams
OptiDreams, licence 80068529: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Platinum Labs Global LLC
- NPN or DIN-HM
- 80068529
- Status
- Active licence
- Licence date
- 14 April 2016
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 5.0 milligramme | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : N-acétyl L-chlorhydrate de carnitine | 500.0 milligramme | Not calculated |
| Nelumbo nucifera Source : Feuille Extract : Matériel brut sec Extraction ratio : 10.000:1 Dry plant equivalent : 3000 milligramme | 300.0 milligramme | Not calculated |
| L-théanine Source : L-Théanine | 250.0 milligramme | Not calculated |
| Taraxacum officinale Source : Taraxacum officinale - Racine Extract : Matériel brut sec Extraction ratio : 4.000:1 Dry plant equivalent : 800 milligramme | 200.0 milligramme | Not calculated |
| Humulus lupulus Source : Plante entière | 50.0 milligramme | Not calculated |
| Vitamine D Source : Cholécalciférol | 25.0 microgrammes | Not calculated |
| Vitamine D Source : Cholécalciférol | 1000.0 UI | Not calculated |
Non-medicinal ingredients
Saveur de limonade, Cétone de framboise, Saveur de mûre, Silice, Sucralose, Saveur de pêche mangue, Feuilles de Camellia Sinensis, Acide citrique, Maltodextrine, Valeriana officinalis
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Mesures | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps to temporarily promote relaxation. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80068529
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.